Integer Holdings (ITGR) Total Non-Current Liabilities (2010 - 2026)
Integer Holdings (ITGR) posted Total Non-Current Liabilities of $1.7 billion for Q2 2026, up 3.09% sequentially from $1.6 billion in Q4 2025, and up 1.88% YoY from $1.7 billion in Q2 2025.
Integer Holdings (ITGR) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Integer Holdings has reported Total Non-Current Liabilities for 17 years, with the latest figure at $1.7 billion in Q2 2026.
- Quarterly Total Non-Current Liabilities rose 1.88% year-over-year to $1.7 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.7 billion (up 1.88% YoY) and the FY2025 annual result came in at $1.6 billion, up 14.69% from the prior year.
- Total Non-Current Liabilities advanced to $1.7 billion in Q2 2026 per ITGR's latest filing, from $1.6 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $1.7 billion in Q2 2026 and troughed at $1.2 billion in Q2 2022.
- A 5-year average of $1.5 billion and a median of $1.4 billion in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities surged 37.64% in 2022, then slipped 0.02% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $1.4 billion in 2022, then gained by 3.36% to $1.4 billion in 2023, then climbed by 1.71% to $1.4 billion in 2024, then climbed by 14.69% to $1.6 billion in 2025, then advanced by 3.09% to $1.7 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.7 billion, $1.6 billion, and $1.6 billion for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Integer Holdings | 4.26 Bn | 4.24 Bn | 112.94 Mn | 1.69 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 1.69 Bn |
| Apr 3, 2026 | 1.69 Bn |
| Dec 31, 2025 | 1.64 Bn |
| Sep 26, 2025 | 1.63 Bn |
| Jun 27, 2025 | 1.64 Bn |
| Mar 28, 2025 | 1.66 Bn |
| Dec 31, 2024 | 1.43 Bn |
| Sep 27, 2024 | 1.52 Bn |
| Jun 28, 2024 | 1.55 Bn |
| Mar 29, 2024 | 1.57 Bn |
| Dec 31, 2023 | 1.41 Bn |
| Sep 29, 2023 | 1.36 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.44 Bn |
| Dec 31, 2022 | 1.36 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jul 1, 2022 | 1.37 Bn |
| Apr 1, 2022 | 1.22 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Oct 1, 2021 | 988.79 Mn |